BEIJING, Oct. 29 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in- vitro diagnostic products today announced that it will be attending the Credit Suisse Asian Healthcare Conference.
Date: November 5, 2008
Location: Beijing, China
China Medical Technologies' management team will discuss the Company's strategy, operations and growth opportunities, as well as its published results to date with securities analysts and institutional portfolio managers.
About China Medical Technologies, Inc.
China Medical Technologies is a leading China-based medical device
company that develops, manufactures and markets advanced in-vitro
diagnostic products using Enhanced Chemiluminescence (ECLIA) technology and
Fluorescent in situ Hybridization (FISH) technology, to detect and monitor
various diseases and disorders, and system using High Intensity Focused
Ultrasound (HIFU) for the treatment of solid cancers and benign tumors. For
more information, please visit http://www.chinameditech.com .
For further information, please contact:
|SOURCE China Medical Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved